Resultados: 17

Novel prognostic score for immediate and late success after percutaneous mitral balloon commissurotomy in patients with mitral stenosis

Arq. bras. cardiol; 117 (5 supl. 1), 2021
INTRODUCTION: Percutaneous mitral balloon commissurotomy (PMBC) remains the preferred treatment for patients with severe symptomatic rheumatic mitral stenosis (MS) and suitable anatomy. OBJECTIVE: The objective of this study was to propose a new score for the prediction of immediate and late success. MET...

Seguimento de longo prazo em pacientes com estenose mitral reumática e hipertensão arterial pulmonar grave submetidos a valvuloplastia mitral percutânea por balão
Long-term follow-up in patients with rheumatic mitral stenosis and severe pulmonary arterial hypertension undergoing mitral valvuloplasty percutaneous balloon

J. Transcatheter Interv; 29 (supl. 1), 2021
INTRODUÇÃO: A valvuloplastia mitral percutânea por balão (VMPB) é uma abordagem terapêutica de escolha em pacientes com estenose mitral. OBJETIVO(s): O objetivo deste estudo foi avaliar os resultados clínicos, ecocardiográficos e hemodinâmicos imediatos e de longo prazo pacientes com hipertenso ...

Preditores clínicos e ecocardiográficos independentes de reestenose após valvuloplastia mitral percutânea por balão após seguimento de até 24 anos
Clinical and echocardiographic predictors independent of restenosis after valvuloplasty percutaneous mitral valve balloon after follow-up up to 24 years old

J. Transcatheter Interv; 29 (supl. 1), 2021
INTRODUÇÃO: A estenose da válvula mitral (EM) é uma das doenças cardíacas estruturais mais comuns nos países em desenvolvimento, principalmente devido à doença reumática. A valvoplastia mitral percutânea por balão (VMPB) tem sido, desde sua introdução em 1984, a opção preferencial de trat...

Independent mitral valve predictors of restenosis after percutaneous mitral balloon commissurotomy in a large, consecutive cohort followed for more than two decades

AIMS: the objective of this study was to enlight risk factors of mitral valvular restenosis in a significant number of patients submitted to percutaneous mitral balloon commissurotomy for the treatment of mitral stenosis (ms), particularly when secondary to rheumatic heart disease. METHODS AND RESULTS: t...

Long-term follow-up in patients with rheumatic mitral stenosis and severe pulmonary artery hypertension submitted to percutaneous mitral balloon commissurotomy

AIMS: Percutaneous balloon mitral commissurotomy (PMBC) is an attractive therapeutic approach in patients with mitral stenosis. The aim of this study was to assess the immediate and long-term clinical, echocardiographic and haemodynamic outcomes of PMBC in patients with severe pulmonary hypertension (PH)...

Independent clinical and echocardiographic predictors of restenosis after percutaneous mitral balloon commissurotomy followed for 24 years

J. Am. Coll. Cardiol; 77 (14 suppl. s), 2021
BACKGROUND Mitral valve stenosis is one of the most common structural heart diseases in developing countries and is primarily due to rheumatic disease. Percutaneous mitral balloon valvuloplasty (PMBV) has been, since its introduction in 1984, the preferred treat ment. However, restenosis presents with an...

Very Long Term Follow-Up After Percutaneous Balloon Mitral Valvuloplasty

JACC cardiovasc. interv; 11 (19), 2018
OBJECTIVES: The aim of this study was to assess very long term outcomes after successful percutaneous balloon mitral valvuloplasty (PBMV).BACKGROUND: PBMV remains the preferred treatment for patients with severe symptomatic rheumatic mitral stenosis and suitable anatomy.METHODS: All consecutive patients ...